THE GIBSON GROUP, LLC for ENDO PHARMACEUTICALS INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to incentives for life sciences research. H.R. 160: Protect Medical Innovation Act of 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH H GIBSON | — |
Copyright/Patent/Trademark CPT
Oversight of implementation of the America Invents Act. Issues relating to patent settlements. H.R. 9: The Innovation Act. S. 1137: Protecting American Talent and Entrepreneurship Act of 2015 (PATENT Act). Issues relating to misuse of the inter pares review process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH H GIBSON | — |
Health Issues HCR
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. Issues relating to Medicare Part D rebates. Compounding and drug supply chain legislation. H.R.471/S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2015. Issues relating to the labeling of generic drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH H GIBSON | Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997 |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.